Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 2 Uterine Cervical Dysplasia 2 Thyroid Nodule 2 Sarcoma 2 Prostatic Neoplasms 2 Melanoma 2 Uterine Neoplasms 1 Uterine Diseases 1 Uterine Cervical Diseases 1 Urogenital Neoplasms 1 Urogenital Diseases 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Spinal Cord Compression 1 Precancerous Conditions 1 Papillomavirus Infections 1 Neoplasms, Unknown Primary 1 Neoplasms by Site 1 Neoplasms 1 Hyperthyroidism 1 Genital Neoplasms, Female 1 Genital Diseases, Female 1 Genital Diseases 1 Gastrointestinal Neoplasms 1 Female Urogenital Diseases and Pregnancy Complications 1 Colorectal Cancer Metastatic 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1 Adenocarcinoma 1 Acquired Immunodeficiency Syndrome 1

Interventions

Fulvestrant 125 Trastuzumab 114 Paclitaxel 113 Letrozole 108 pembrolizumab 79 pertuzumab 75 palbociclib 75 Capecitabine 72 Anastrozole 72 Cyclophosphamide 70 Carboplatin 67 abemaciclib 64 exemestane 63 Tamoxifen 63 ribociclib 60 trastuzumab deruxtecan 57 Surveys and Questionnaires 51 Specimen Handling 50 Radiotherapy 49 Docetaxel 49 Magnetic Resonance Spectroscopy 48 Blood Specimen Collection 40 olaparib 39 Standard of Care 36 Biopsy 33 sacituzumab govitecan 31 130-nm albumin-bound paclitaxel 31 Doxorubicin 30 Exercise 29 eribulin 27

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasms × Transurethral Resection of Prostate × 1 year × Clear all

NCT07483996 2026-03-19

CRYSTAL

Franciscus Gasthuis & Vlietland (Hospital)

Phase 3 Not yet recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡